amifostine anhydrous and sodium pertechnetate tc 99m

amifostine anhydrous has been researched along with sodium pertechnetate tc 99m in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, S; Meyerowitz, C; Rubin, P; Smudzin, T1
Bohuslavizki, KH; Brenner, W; Clausen, M; Feyerabend, B; Henze, E; Hübner, RH; Klutmann, S; Lassmann, S; Lüttges, J; Tinnemeyer, S1
Bohuslavizki, KH; Brenner, W; Clausen, M; Henze, E; Klutmann, S; Mester, J1
Bleckmann, C; Bohuslavizki, KH; Brenner, W; Clausen, M; Henze, E; Klutmann, S; Lassmann, S; Mester, J1
Bohuslavizki, KH; Brenner, W; Clausen, M; Feyerabend, B; Henze, E; Jenicke, L; Klutmann, S1
Mandel, L; Mandel, SJ1
Debus, J; Haberkorn, U; Herfarth, KK; Hof, H; Hoffner, S; Huber, P; Karger, CP; Münter, MW; Rudat, V1
Bhartiya, US; Hawaldar, RW; Jambhekar, NA; Joseph, LJ; Nayak, Y; Pawar, YP; Rajan, MG; Raut, YS1

Reviews

1 review(s) available for amifostine anhydrous and sodium pertechnetate tc 99m

ArticleYear
Radioactive iodine and the salivary glands.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:3

    Topics: Amifostine; Carcinoma, Papillary; Humans; Iodine Radioisotopes; Radiation Injuries; Radiation-Protective Agents; Radionuclide Imaging; Salivary Gland Diseases; Salivary Glands; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms

2003

Trials

3 trial(s) available for amifostine anhydrous and sodium pertechnetate tc 99m

ArticleYear
Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction.
    International journal of radiation oncology, biology, physics, 1994, Jul-01, Volume: 29, Issue:4

    Topics: Amifostine; Feasibility Studies; Head and Neck Neoplasms; Humans; Parotid Gland; Pilot Projects; Radiation Protection; Radiotherapy Dosage; Salivary Glands; Secretory Rate; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m

1994
Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:11

    Topics: Adenocarcinoma, Follicular; Adult; Amifostine; Carcinoma, Papillary; Double-Blind Method; Female; Humans; Iodine Radioisotopes; Male; Placebos; Radiation-Protective Agents; Radionuclide Imaging; Salivary Glands; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms

1998
Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:2

    Topics: Adult; Aged; Amifostine; Carcinoma, Papillary; Drug Evaluation; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiation-Protective Agents; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salivary Glands; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms; Time Factors; Xerostomia

1999

Other Studies

4 other study(ies) available for amifostine anhydrous and sodium pertechnetate tc 99m

ArticleYear
Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:7

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Amifostine; Animals; Carcinoma, Papillary; Case-Control Studies; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Rabbits; Radiation-Protective Agents; Radionuclide Imaging; Radiotherapy Dosage; Salivary Glands; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms

1998
Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.
    International journal of radiation oncology, biology, physics, 1999, Aug-01, Volume: 45, Issue:1

    Topics: Amifostine; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Iodine Radioisotopes; Male; Rabbits; Radiation-Protective Agents; Radiobiology; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Salivary Glands; Sodium Pertechnetate Tc 99m

1999
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    International journal of radiation oncology, biology, physics, 2007, Mar-01, Volume: 67, Issue:3

    Topics: Adult; Aged; Amifostine; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Logistic Models; Male; Middle Aged; Parotid Gland; Radiation-Protective Agents; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Salivary Glands; Salivation; Sodium Pertechnetate Tc 99m; Xerostomia

2007
Radioprotective effect of Ocimum sanctum and amifostine on the salivary gland of rats after therapeutic radioiodine exposure.
    Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:6

    Topics: Amifostine; Animals; Female; Iodine Radioisotopes; Ocimum; Parotid Gland; Phytotherapy; Plant Preparations; Radiation-Protective Agents; Radiopharmaceuticals; Radiotherapy; Rats; Rats, Wistar; Sodium Pertechnetate Tc 99m; Tissue Distribution

2011